Health copyright explained to the Star it has contacted Adastra to “reiterate the very slender parameters of their licence.” The corporate subsequently issued a second release Friday retracting what it said in its first assertion and noting: “This kind of statements really should not be relied upon.”Meanwhile, cannabis extractions firm Adas